Ab­b­Vie puts up fight against Orilis­sa gener­ics from San­doz, Te­va and oth­ers

Sev­er­al drug­mak­ers, in­clud­ing San­doz and Te­va, are bank­ing on swift ap­provals for their gener­ic ver­sions of the en­dometrio­sis drug Orilis­sa — but not if Ab­b­Vie can …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.